Kamada (KMDA) Depreciation and Depletion (2018 - 2024)
Kamada (KMDA) reported Depreciation and Depletion of $3.2 million for Q3 2024, up 1.98% on a YoY basis from $3.2 million in Q4 2023, and up 1.06% quarter-over-quarter from $3.2 million in Q4 2023.
Kamada (KMDA) Depreciation and Depletion (2018 - 2024) Analysis & Trends
Kamada has reported Depreciation and Depletion for 4 years, with the latest figure at $3.2 million in Q3 2024.
- For the quarter ending Q3 2024, Depreciation and Depletion rose 1.98% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2024 stood at $10.8 million (up 77.22% YoY), and the FY2023 full-year result was $12.7 million, changed N/A from the prior year.
- Depreciation and Depletion for Q3 2024 stood at $3.2 million, up from $3.2 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $3.2 million in Q3 2024, with the low at $3.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Dec 31, 2018 | 889,000.00 |
| Dec 31, 2018 | 889,000.00 |
| Sep 30, 2018 | 874,000.00 |
| Sep 30, 2018 | 874,000.00 |